P117 real-world perspectives of health care providers delivering the first approved treatment for peanut allergy
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY(2021)
摘要
In January 2020, Peanut (Arachis hypogaea) Allergen Powder-dnfp (PTAH) became the first treatment for Peanut Allergy (PA) approved by the US Food and Drug Administration (FDA). The adoption of innovative new therapies requires consideration of the skills, logistics and practicalities required for implementation.
更多查看译文
关键词
peanut allergy,first approved treatment,health care,real-world
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要